IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q1 2017 Holdings

Filed 2017-05-12 | 25 holdings | $7.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$4.2M140,00057.8%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$2.8M100,00038.7%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$72.4K1,596,7011.0%
Alder BioPharmaceuticals, Inc.(ALDR1EUR)COM014339105$33.9K1,629,2220.5%
Achaogen, Inc.COM004449104$31.4K1,245,1870.4%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$19.8K912,0010.3%
Wave Life Sciences Ltd.(WVE)SHSY95308105$18.6K676,1280.3%
Epizyme, Inc.(EPZMEUR)COM29428V104$11.7K681,9220.2%
Bellicum Pharmaceuticals, Inc.COM079481107$11.3K918,0000.2%
Blueprint Medicines Corporation(2L9)COM09627Y109$10.4K260,4000.1%
NanoString Technologies, Inc.(NSTGEUR)COM63009R109$6.3K318,5860.1%
Dermira, Inc.(DERMEUR)COM24983L104$6.0K176,2110.1%
Momenta Pharmaceuticals, Inc.(MNTA)COM60877T100$5.7K430,6320.1%
Protagonist Therapeutics, Inc.(PTGX)COM74366E102$4.4K346,2810.1%
Loxo Oncology, Inc.COM548862101$4.2K100,0000.1%
iRhythm Technologies, Inc.(IRTC)COM450056106$2.6K70,0100.0%
Natera, Inc.(NTRA)COM632307104$2.5K285,7310.0%
Fibrogen, Inc.(FGENEUR)COM31572Q808$2.2K87,9840.0%
Intellia Therapeutics, Inc.(NTLA)COM45826J105$2.1K150,0000.0%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$2.0K91,6000.0%
Zafgen, Inc.COM98885E103$1.7K370,8760.0%
Orexigen Therapeutics, Inc.COM686164302$1.3K380,5300.0%
Audentes Therapeutics, Inc.(BOLDEUR)COM05070R104$1.1K66,5530.0%
Immunomedics, Inc.(IMMU)COM452907108$1.1K172,8710.0%
Acceleron Pharma Inc.(XLRN)COM00434H108$52619,8860.0%